TCG Crossover Management as of March 31, 2024
Portfolio Holdings for TCG Crossover Management
TCG Crossover Management holds 33 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology Comm (CGON) | 12.4 | $157M | 3.6M | 43.90 | |
| Dyne Therapeutics Comm (DYN) | 5.9 | $75M | 2.7M | 28.39 | |
| Astria Therapeutics Comm (ATXS) | 5.9 | $74M | 5.3M | 14.07 | |
| Silence Therapeutics Adrs (SLN) | 5.6 | $71M | 3.3M | 21.60 | |
| Structure Therapeutics Adrs (GPCR) | 5.4 | $69M | 1.6M | 42.86 | |
| Aerovate Therapeutics Comm (AVTE) | 5.1 | $65M | 2.2M | 29.57 | |
| Inhibrx Comm | 4.8 | $61M | 1.8M | 34.96 | |
| Keros Therapeutics Comm (KROS) | 4.6 | $58M | 879k | 66.20 | |
| Geron Corp Comm (GERN) | 4.5 | $57M | 17M | 3.30 | |
| Savara Comm (SVRA) | 3.9 | $50M | 10M | 4.98 | |
| Ocular Therapeutix Comm (OCUL) | 3.8 | $48M | 5.3M | 9.10 | |
| Cogent Biosciences Comm (COGT) | 3.3 | $42M | 6.2M | 6.72 | |
| Edgewise Therapeutics Comm (EWTX) | 3.3 | $42M | 2.3M | 18.24 | |
| Mineralys Therapeutics Comm (MLYS) | 3.3 | $41M | 3.2M | 12.91 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 3.2 | $40M | 149k | 267.04 | |
| Tourmaline Bio Comm (TRML) | 2.7 | $34M | 1.5M | 22.90 | |
| Tyra Biosciences Comm (TYRA) | 2.6 | $33M | 2.0M | 16.40 | |
| Compass Pathways Adrs (CMPS) | 2.5 | $32M | 3.9M | 8.32 | |
| Kura Oncology Comm (KURA) | 2.4 | $30M | 1.4M | 21.33 | |
| Tarsus Pharmaceuticals Comm (TARS) | 2.3 | $29M | 794k | 36.35 | |
| Adverum Biotechnologies Comm | 2.2 | $28M | 2.0M | 14.14 | |
| Soleno Therapeutivs Comm | 1.9 | $24M | 550k | 42.80 | |
| Centessa Pharmaceuticals Comm (CNTA) | 1.8 | $23M | 2.0M | 11.30 | |
| Abivax SA Adrs (ABVX) | 1.2 | $16M | 1.1M | 14.30 | |
| Vistagen Therapeutics Comm | 1.1 | $14M | 2.7M | 5.28 | |
| Kalvista Pharmaceuticals Comm (KALV) | 1.1 | $14M | 1.2M | 11.86 | |
| C4 Therapeutics Comm (CCCC) | 0.8 | $10M | 1.3M | 8.17 | |
| Entrada Therapeutics Comm (TRDA) | 0.7 | $8.3M | 585k | 14.17 | |
| AN2 Therapeutics Comm (ANTX) | 0.4 | $5.1M | 1.6M | 3.25 | |
| Kodiak Sciences Comm (KOD) | 0.4 | $4.7M | 900k | 5.26 | |
| Ventyx Biosciences Comm (VTYX) | 0.4 | $4.5M | 816k | 5.50 | |
| Nektar Therapeutics Comm | 0.3 | $3.7M | 4.0M | 0.93 | |
| Cabaletta Bio Comm (CABA) | 0.1 | $1.5M | 87k | 17.06 |
